Operating Segments

9 Months Ended

Sep. 30, 2021

Operating Segments

Operating Segments

Note 10. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	Three Months Ended
	September 30,
	2021		2020
Revenues
Public Health Solutions	$	186,198	$	544,466
Specialized BioTherapeutics		—		64,345
Total	$	186,198	$	608,811
Loss from Operations
Public Health Solutions	$	(303,488)	$	(6,369)
Specialized BioTherapeutics		(1,799,898)		(643,793)
Corporate		(1,271,996)		(1,162,615)
Total	$	(3,375,382)	$	(1,812,777)
Amortization and Depreciation Expense
Public Health Solutions	$	314	$	6,651
Specialized BioTherapeutics		1,883		3,201
Corporate		6,678		7,335
Total	$	8,875	$	17,187
Other Income, Net
Specialized BioTherapeutics	$	(26,123)		22,131
Corporate		(186,046)		486
Total	$	(212,169)	$	22,617
Share-Based Compensation
Public Health Solutions	$	6,518	$	8,377
Specialized BioTherapeutics		28,506		18,962
Corporate		44,697		39,233
Total	$	79,721	$	66,572

	Nine Months Ended
	September 30,
	2021		2020
Revenues
Public Health Solutions	$	548,615	$	1,921,284
Specialized BioTherapeutics		—		117,369
Total	$	548,615	$	2,038,653
Loss from Operations
Public Health Solutions	$	(666,223)	$	(215,608)
Specialized BioTherapeutics		(4,632,872)		(9,810,296)
Corporate		(3,319,539)		(3,074,534)
Total	$	(8,618,634)	$	(13,100,438)
Amortization and Depreciation Expense
Public Health Solutions	$	941	$	21,272
Specialized BioTherapeutics		5,644		9,438
Corporate		20,029		21,925
Total	$	26,614	$	52,635
Other Income/(Loss), Net
Specialized BioTherapeutics	$	99,512	$	90,838
Corporate		(192,717)		24,450
Total	$	(93,205)	$	115,288
Share-Based Compensation
Public Health Solutions	$	20,002	$	26,219
Specialized BioTherapeutics		86,816		63,213
Corporate		148,329		121,834
Total	$	255,147	$	211,266

	As of		As of
	September 30,		December 31,
	2021		2020
Identifiable Assets
Public Health Solutions	$	48,885	$	176,447
Specialized BioTherapeutics		72,483		147,784
Corporate		29,596,430		19,567,004
Total	$	29,717,798	$	19,891,235